 The BT-002 is an exploratory pharmacodynamic study that is being performed to evaluate the effect of Botulism Antitoxins in preventing paralysis of extensor digitorum brevis muscle following BOTOX MYOBLOC administration. This study will compare bivalent and heptavalent products to a placebo. Safety data will be collected. 